Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: DYNPORT VACCINE COMPANY LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2013-05-09 to 2023-05-22
Current total value of award: $257417661.13
Description: EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.